After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J vaccine recipients, and Dr. Kavita Patel, a practicing physician and former health official in President Obama’s administration, considers the pause’s impact on vaccine supply, timeline goals, and vaccine hesitancy among Americans.